Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Part 1
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Caroline Helwick
Authored Items
High Rates of Vancomycin-Resistant Enterococci Bacteremia Observed in Patients Receiving Allogeneic Hematopoietic Stem-Cell Transplant
Caroline Helwick
TOP - February 2017, Vol 10, No 1
in
Supportive Care
NCCN Campaign May Prevent Fatal Medication Errors by Targeting Vincristine Preparation
Caroline Helwick
TOP - February 2017, Vol 10, No 1
in
Best Practices
Multivitamin Use During Chemotherapy May Reduce Risk for Peripheral Neuropathy
Caroline Helwick
TOP - August 2016, Vol 9, No 3
in
Supportive Care
“Overreaction” to Oxaliplatin Hypersensitivity Reactions
Caroline Helwick
TOP - August 2016, Vol 9, No 3
Acute Myeloid Leukemia: Understanding the Patient’s Experience
Caroline Helwick
TOP - May 2016, Vol 9, No 2
in
Hematologic Cancers
LMWH Protocol for Thrombocytopenia Validated in Study
Caroline Helwick
TOP - February 2016, Vol 9, No 1
Antibacterial Prophylaxis Reduces Infections During Induction Chemotherapy for ALL
Caroline Helwick
TOP - February 2016, Vol 9, No 1
in
Hematologic Cancers
ASBMT Pharmacy SIG Reports Growth, Opportunities for Pharmacists
Caroline Helwick
TOP - May 2015, Vol 8, No 2
in
Conference Correspondent
Generic Docetaxel Increases Neutropenia Risk and Healthcare Costs
Caroline Helwick
TOP - October 2014, Vol 7, No 4
in
Supportive Care
Relation Between Stomatitis and Clinical Outcomes of Everolimus Treatment Examined by Trial Investigators
Caroline Helwick
TOP - October 2014, Vol 7, No 4
in
Breast Cancer
Less May Be “More” With Zoledronic Acid
Caroline Helwick
TOP - October 2014, Vol 7, No 4
in
Breast Cancer
Maximizing Safety of Chemotherapeutic Drugs During Pregnancy
Caroline Helwick
TOP - May 2014, Vol 7, No 2
in
Best Practices
For Cancer-Induced Anemia, ESAs Best Given With IV Iron
Caroline Helwick
TOP - May 2014, Vol 7, No 2
in
Supportive Care
Monoclonal Antibodies for Multiple Myeloma
Caroline Helwick
TOP - May 2014, Vol 7, No 2
in
Hematologic Cancers
340B Pricing—Who Wins, Who Loses?
Caroline Helwick
TOP - May 2014, Vol 7, No 2
Benefit Shown for Pomalidomide 4 mg Daily on Intermittent Schedule
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Hematologic Cancers
Eribulin Mesylate Plus Trastuzumab Yields High Response Rates as First-Line Metastatic Breast Cancer Treatment
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Breast Cancer
NEPA Superior to Palonosetron in CINV Prevention
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Supportive Care
Osteonecrosis of the Jaw Associated With Cumulative Dose in Myeloma
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Supportive Care
Understanding FOLFOX Toxicity: Some Subsets Have Higher Risks
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Supportive Care
Same-Day G-CSF Shown Acceptable for Patients With NHL
Caroline Helwick
TOP - February 2014, Vol 7, No 1
in
Hematologic Cancers
Off-Label Drug Use Accounts for 18% of Spending
Caroline Helwick
TOP - October 2013 VOL 6, NO 4
in
Drug Updates
Surveys Confirm Drug Shortages Are a Persistent Problem
Caroline Helwick
TOP - October 2013 VOL 6, NO 4
in
Drug Updates
Superior Efficacy Shown for Novel Fixed-Dose Antiemetic Combination
Caroline Helwick
TOP - August 2013 VOL 6, NO 3
in
Supportive Care
Additional Analyses of Eribulin Study Find Quality of Life, Survival Benefits
Caroline Helwick
TOP - August 2013 VOL 6, NO 3
in
Breast Cancer
Branded Versus Generic Enoxaparin: Biological Activity May Differ
Caroline Helwick
TOP - August 2013 VOL 6, NO 3
in
Conference Correspondent
Abstracts of Interest From the 54th Annual Meeting of the American Society of Hematology
Caroline Helwick
TOP - May 2013, Vol 6, No 2
in
Conference Correspondent
Head to Head in Metastatic Renal Cell Carcinoma: Pazopanib Favored
Caroline Helwick
TOP - May 2013, Vol 6, No 2
in
Genitourinary Cancers
Liposomal Vincristine Allows for Greater Dose Density Without Increased Neurotoxicity
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Hematologic Cancers
Venlafaxine Lowers Endoxifen Levels, May Affect Tamoxifen Effectiveness
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Breast Cancer
Cryotherapy Effective for Oral Mucositis
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
GVHD Reduced With Vorinostat
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
In PACE Update, Ponatinib Benefit Confirmed
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
Genes Linked to Anthracycline- Related Congestive Heart Failure
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
Genetic Profile Predicts Mortality in African American and Asian Pediatric Patients With AML
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
Evidence Grows for Bendamustine-Rituximab Combination for Lymphoma
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Conference Correspondent
Bisphosphonates Should Not Be Routine in Early Breast Cancer
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Breast Cancer
SNP Networks Identify Risk for Adverse Effects of Chemotherapy
Caroline Helwick
TOP - February 2013 VOL 6, NO 1
in
Supportive Care
Advances in the Treatment of Pancreatic Neuroendocrine Tumors
Caroline Helwick
TOP - December 2012 VOL 5, NO 8
in
Rare Cancers
Catheter-Related Thrombosis Can Be Prevented
Caroline Helwick
TOP - December 2012 VOL 5, NO 8
in
Supportive Care
Continued Benefit for Everolimus in Updated Results of BOLERO-2
Caroline Helwick
TOP - October 2012 VOL 5, NO 7
in
Breast Cancer
Zoledronic Acid: Less Frequent Dosing May Be Just as Good
Caroline Helwick
TOP - October 2012 VOL 5, NO 7
in
Breast Cancer
Chemotherapy-Related Adverse Events Add to Economic Burden in Metastatic Breast Cancer
Caroline Helwick
TOP - October 2012 VOL 5, NO 7
in
Breast Cancer
Weight-Based Dosing Is Appropriate for Obese Patients
Caroline Helwick
TOP - October 2012 VOL 5, NO 7
in
Best Practices
Highlights From ASCO 2012 Breast Cancer Symposium
Caroline Helwick
TOP - October 2012 VOL 5, NO 7
in
Conference Correspondent
Mucositis Management to Become More Personalized
Caroline Helwick
TOP - September 2012, Vol 5, No 6
in
Supportive Care
For Palliation of Severe Dysphagia, Small-Caliber Stents Work Well With Fewer Complications
Caroline Helwick
Online First
in
Conference Correspondent
Estrogen Alone Poses No Increased Breast Cancer Risk
Caroline Helwick
Web Exclusives
in
Breast Cancer
,
In the News
Patients Discovering Breast CancerTrials.org
Caroline Helwick
Web Exclusives
in
Breast Cancer
,
In the News
Preoperative Anti-HER2 Agents Yield Benefits
Caroline Helwick
Web Exclusives
in
Drug Therapies
,
In the News
Novel Agent Has Striking Activity in Lung Cancer Subset
Caroline Helwick
Online First
Last modified: December 11, 2015
Home
Issues
2022
May 2022 - Vol 15 No 3
March 2022 - Vol 15 No 2
January 2022 - Vol 15 No 1 – Online Only
2021
November 2021 - Vol 14 No 7
October 2021 - Vol 14 No 6 | Biosimilars
September 2021 - Vol 14 No 5
July 2021 - Vol 14 No 4
May 2021 - Vol 14 No 3
March 2021 - Vol 14 No 2
January 2021 - Vol 14 No 1
2020
November 2020, Vol 13, No 6
September 2020 - Vol 13 no 5
July 2020 - Vol 13 no 4
May 2020 - Vol 13 no 3
March 2020 - Vol 13 no 2
January 2020 - Vol 13 No 1
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
Issue Archive
Special Issues
Supplements
ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
Part 1
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
ASCO 2021 Wrap-Up - Breast Cancer
Web Exclusives
Ovarian Cancer Overview
Interview with the Innovators
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP
Print Edition
We will request your mailing address on the next page.
TOP
E-Newsletters and Communications
JHOP
Print Edition
We will request your mailing address on the next page.
JHOP
E-Newsletters and Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
